Filing Details
- Accession Number:
- 0001315863-24-000263
- Form Type:
- 13G Filing
- Publication Date:
- 2024-02-13 19:00:00
- Filed By:
- Antara Capital
- Company:
- Revance Therapeutics Inc. (NASDAQ:RVNC)
- Filing Date:
- 2024-02-14
- SEC Url:
- 13G Filing
Ownership Summary
Please notice the below summary table is generated without human intervention and may contain errors. Please refer to the complete filing displayed below for exact figures.
| Name | Sole Voting Power | Shared Voting Power | Sole Dispositive Power | Shared Dispositive Power | Aggregate Amount Owned Power | Percent of Class |
|---|---|---|---|---|---|---|
| Antara Capital | 0 | 0 | 0 | 0 | 0 | 0% |
| Antara Capital GP | 0 | 0 | 0 | 0 | 0 | 0% |
| Himanshu Gulati | 0 | 0 | 0 | 0 | 0 | 0% |
Filing
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 13G
(Amendment No. 1)
(Rule 13d-102)
INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO
RULES 13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED
PURSUANT TO RULE 13d-2(b)
Revance Therapeutics, Inc.
(Name of Issuer)
Common Stock, $.001 par value
(Title of Class of Securities)
761330109
(CUSIP Number)
December 31, 2023
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
| ☒ | Rule 13d-1(b) |
| ☐ | Rule 13d-1(c) |
| ☐ | Rule 13d-1(d) |
| * | The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter
disclosures provided in a prior cover page. |
The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that
section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
CUSIP No. 761330109
| 1 | | NAME OF REPORTING PERSONS Antara Capital LP | ||||||||||||||||
| 2 | | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) ☐ (b) ☒ | ||||||||||||||||
| 3 | | SEC USE ONLY | ||||||||||||||||
| 4 | | CITIZENSHIP OR PLACE OF ORGANIZATION Delaware | ||||||||||||||||
| NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH | | 5 | | SOLE VOTING POWER 0 | ||||||||||||||
| | 6 | | SHARED VOTING POWER 0 | |||||||||||||||
| | 7 | | SOLE DISPOSITIVE POWER 0 | |||||||||||||||
| | 8 | | SHARED DISPOSITIVE POWER 0 | |||||||||||||||
| 9 | | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 0 | ||||||||||||||||
| 10 | | CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES* ☐ | ||||||||||||||||
| 11 | | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 0%** | ||||||||||||||||
| 12 | | TYPE OF REPORTING PERSON* PN, IA | ||||||||||||||||
| * | | SEE INSTRUCTIONS BEFORE FILLING OUT |
| ** | | SEE ITEM 4. |
CUSIP No. 761330109
| 1 | | NAME OF REPORTING PERSONS Antara Capital GP LLC | ||||||||||||||||
| 2 | | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) ☐ (b) ☒ | ||||||||||||||||
| 3 | | SEC USE ONLY | ||||||||||||||||
| 4 | | CITIZENSHIP OR PLACE OF ORGANIZATION Delaware | ||||||||||||||||
| NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH | | 5 | | SOLE VOTING POWER 0 | ||||||||||||||
| | 6 | | SHARED VOTING POWER 0 | |||||||||||||||
| | 7 | | SOLE DISPOSITIVE POWER 0 | |||||||||||||||
| | 8 | | SHARED DISPOSITIVE POWER 0 | |||||||||||||||
| 9 | | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 0 | ||||||||||||||||
| 10 | | CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES* ☐ | ||||||||||||||||
| 11 | | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 0%** | ||||||||||||||||
| 12 | | TYPE OF REPORTING PERSON* OO | ||||||||||||||||
| * | | SEE INSTRUCTIONS BEFORE FILLING OUT |
| ** | | SEE ITEM 4. |
CUSIP No. 761330109
| 1 | | NAME OF REPORTING PERSONS Himanshu Gulati | ||||||||||||||||
| 2 | | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) ☐ (b) ☒ | ||||||||||||||||
| 3 | | SEC USE ONLY | ||||||||||||||||
| 4 | | CITIZENSHIP OR PLACE OF ORGANIZATION USA | ||||||||||||||||
| NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH | | 5 | | SOLE VOTING POWER 0 | ||||||||||||||
| | 6 | | SHARED VOTING POWER 0 | |||||||||||||||
| | 7 | | SOLE DISPOSITIVE POWER 0 | |||||||||||||||
| | 8 | | SHARED DISPOSITIVE POWER 0 | |||||||||||||||
| 9 | | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 0 | ||||||||||||||||
| 10 | | CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES* ☐ | ||||||||||||||||
| 11 | | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 0%** | ||||||||||||||||
| 12 | | TYPE OF REPORTING PERSON* IN | ||||||||||||||||
| * | | SEE INSTRUCTIONS BEFORE FILLING OUT |
| ** | | SEE ITEM 4. |
AMENDMENT NO. 1 TO SCHEDULE 13G
| Item 1(a) | Name of Issuer. |
Revance Therapeutics, Inc. (the “Issuer”)
| Item 1(b) | Address of Issuer’s Principal Executive Offices. |
1222 Demonbreun Street, Suite 2000, Nashville, Tennessee, 37203
| Item 2(a) | Name of Person Filing. |
This Schedule 13G is being filed by
| (i) | Antara Capital LP (“Antara Capital”) |
| (ii) | Antara Capital GP LLC (“Antara GP”) |
| (iii) | Himanshu Gulati (“Mr. Gulati”) |
| Item 2(b) | Address of Principal Business Office, or, if none, Residence. |
The principal business address of each of the Reporting Persons is:
55 Hudson Yards, 47th Floor, Suite C
New York, NY 10001
| Item 2(c) | Citizenship or Place of Organization. |
| (i) | Antara Capital is a Delaware limited partnership |
| (ii) | Antara GP is a Delaware limited liability company |
| (iii) | Mr. Gulati is an individual and is a citizen of the United States. |
| Item 2(d) | Title of Class of Securities. |
Common Stock, $.001 par value (the “Common Stock”).
| Item 2(e) | CUSIP Number. |
761330109
| Item 3 | Reporting Person. |
If this statement is filed pursuant to Rule 13d-1(b), or 13d-2(b), check whether the person filing is a:
| (a) | | ☐ | | Broker or dealer registered under Section 15 of the Exchange Act. |
| (b) | | ☐ | | Bank as defined in section 3(a)(6) of the Exchange Act. |
| (c) | | ☐ | | Insurance company as defined in section 3(a)(19) of the Exchange Act. |
| (d) | | ☐ | | Investment company registered under section 8 of the Investment Company Act of 1940. |
| (e) | | ☒ | | An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E). |
| (f) | | ☐ | | An employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F). |
| (g) | | ☒ | | A parent holding company or control person in accordance with Rule 13d 1(b)(1)(ii)(G). |
| (h) | | ☐ | | A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act. |
| (i) | | ☐ | | A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940. |
| (j) | | ☐ | | Group, in accordance with Rule 13d-1(b)(1)(ii)(J). |
| Item 4 | Ownership. |
Items 5 through 9 and 11 of each of the cover pages to this Schedule 13G are incorporated herein by reference.
As of December 31, 2023, Antara Capital Master Fund LP (“Antara Master Fund”) did not hold any shares of Common Stock.
As of December 31, 2023, the Reporting Persons in the aggregate beneficially owned 0% of the shares of Common Stock outstanding.
Antara Capital is the investment manager of the Antara Master Fund. Antara GP is the general partner of Antara Capital. Mr. Gulati is the sole member of Antara GP. Antara Capital, Antara GP and Mr. Gulati may have been
deemed to beneficially own the securities of the Issuer previously held directly by Antara Master Fund.
| Item 5 | Ownership of Five Percent or Less of a Class. |
If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following: ☒
| Item 6 | Ownership of More Than Five Percent on Behalf of Another Person. |
Not applicable.
| Item 7 | Identification and Classification of the Subsidiary which Acquired the Security Being Reported On by the Parent Holding Company. |
Not applicable.
| Item 8 | Identification and Classification of Members of the Group. |
Not applicable.
| Item 9 | Notice of Dissolution of Group. |
Not applicable.
| Item 10 | Certification. |
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose
of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
Date: February 14, 2024
| ANTARA CAPITAL LP | ||
| By: | | Antara Capital GP LLC, its general partner |
| By: | | /s/ Himanshu Gulati |
| | Name: Himanshu Gulati Title: Managing Member | |
| ANTARA CAPITAL GP LLC | ||
| By: | | /s/ Himanshu Gulati |
| | Name: Himanshu Gulati Title: Managing Member | |
| By: | | /s/ Himanshu Gulati |
| | Name: Himanshu Gulati Title: Managing Member | |